This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Università Degli Studi Di Brescia, Universita′ Degli Studi Di Milano. Active years: 2026.
Company Filing History:
1 out of 5 
1 out of 40 Years Active: 2026
Title: Francesca Longhena: Innovator in Parkinson's Disease Research
Introduction
Francesca Longhena is a notable inventor based in Nuvolento, Italy. She has made significant contributions to the field of medical research, particularly in the area of Parkinson's disease. Her innovative work focuses on developing compounds that can modify the progression of this debilitating condition.
Latest Patents
Francesca Longhena holds a patent for "Structural analogues of methylphenidate as Parkinson's disease-modifying agents." This invention describes compounds of formula (A) that are used as modifying agents for Parkinson's disease. Remarkably, it has been discovered that these compounds can significantly reduce alpha-synuclein aggregation and stimulate the functional interaction between alpha-synuclein and Synapsin III. She has 1 patent to her name.
Career Highlights
Throughout her career, Francesca has worked with prestigious institutions such as Università Degli Studi Di Brescia and Università Degli Studi Di Milano. Her research has garnered attention for its potential impact on the treatment of Parkinson's disease.
Collaborations
Francesca has collaborated with talented individuals in her field, including Arianna Bellucci and Valentina Straniero. These partnerships have contributed to the advancement of her research and the development of innovative solutions for Parkinson's disease.
Conclusion
Francesca Longhena is a pioneering inventor whose work in Parkinson's disease research is making a difference in the medical community. Her dedication to innovation and collaboration continues to inspire others in the field.